Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsisRajesh K. Thimmulappa|Journal of Clinical Investigation|2006Cited by 1k
Decline in NRF2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, DJ-1Deepti Malhotra, Shyam Biswal, Ana Navas‐Acién et al.|American Journal of Respiratory and Critical Care Medicine|2008Cited by 354
NRF2 signaling is repressed in HPV-driven head and neck cancer and correlates with better prognosis: HPV-E6/E7 confers chemosensitivity by inhibiting NRF2Pushkal Sinduvadi Ramesh, Rajesh K. Thimmulappa|Research Square|2022Cited by 1
Human Papillomavirus-driven repression of NRF2 signaling confers chemosensitivity and predicts prognosis in head and neck squamous cell carcinomaPushkal Sinduvadi Ramesh, Rajesh K. Thimmulappa|Research Square|2022Cited by 0